Celularity receives Nasdaq delisting notice for late Q2 2024 10-Q and continued Q1 2024 10-Q delinquency

Celularity Inc

Nasdaq notified Celularity on Aug 22, 2024 of non-compliance with Listing Rule 5250(c)(1) due to failure to timely file Q2 2024 10-Q and continued delinquency in Q1 2024 10-Q.
Celularity must submit a compliance plan by September 6, 2024; if accepted, has until October 14, 2024 to implement.
Listing on Nasdaq Capital Market continues under CELU and CELUW without immediate effect.
Celularity intends to submit a plan but cautions no assurance of acceptance or future compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.